Barozzi N - Search Results

1

Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.

Abdel-Aal AB, Batzloff MR, Fujita Y, Barozzi N, Faria A, Simerska P, Moyle PM, Good MF, Toth I. Abdel-Aal AB, et al. Among authors: barozzi n. J Med Chem. 2008 Jan 10;51(1):167-72. doi: 10.1021/jm701091d. Epub 2007 Dec 12. J Med Chem. 2008. PMID: 18072728

2

Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.

Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF. Olive C, et al. Among authors: barozzi n. J Infect Dis. 2006 Jun 15;193(12):1666-76. doi: 10.1086/504266. Epub 2006 May 10. J Infect Dis. 2006. PMID: 16703510

3

Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide.

Everett RS, Vanhook MK, Barozzi N, Toth I, Johnson LG. Everett RS, et al. Among authors: barozzi n. Mol Pharmacol. 2006 Feb;69(2):492-500. doi: 10.1124/mol.105.017251. Epub 2005 Nov 15. Mol Pharmacol. 2006. PMID: 16288084

4

What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?

Barozzi N, Tett SE. Barozzi N, et al. Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1184-91. doi: 10.1002/pds.1451. Pharmacoepidemiol Drug Saf. 2007. PMID: 17636557

5

Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada.

Tett SE, Sketris I, Cooke C, van Zanten SV, Barozzi N. Tett SE, et al. Among authors: barozzi n. Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):735-43. doi: 10.1002/pds.3442. Epub 2013 Apr 4. Pharmacoepidemiol Drug Saf. 2013. PMID: 23559528

6

Perceived barriers to paracetamol (acetaminophen) prescribing, especially following rofecoxib withdrawal from the market.

Barozzi N, Tett SE. Barozzi N, et al. Clin Rheumatol. 2009 May;28(5):509-19. doi: 10.1007/s10067-008-1077-8. Epub 2009 Jan 9. Clin Rheumatol. 2009. PMID: 19132456

7

Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada).

Barozzi N, Sketris I, Cooke C, Tett S. Barozzi N, et al. Br J Clin Pharmacol. 2009 Jul;68(1):106-15. doi: 10.1111/j.1365-2125.2009.03410.x. Br J Clin Pharmacol. 2009. PMID: 19660008 Free PMC article.

8

Actions following adverse drug events - how do these influence uptake and utilisation of newer and/or similar medications?

Barozzi N, Peeters GM, Tett SE. Barozzi N, et al. BMC Health Serv Res. 2015 Nov 6;15:498. doi: 10.1186/s12913-015-1165-9. BMC Health Serv Res. 2015. PMID: 26545734 Free PMC article.

9

Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia.

Barozzi N, Tett SE. Barozzi N, et al. BMC Health Serv Res. 2008 Sep 24;8:196. doi: 10.1186/1472-6963-8-196. BMC Health Serv Res. 2008. PMID: 18816393 Free PMC article.

10

Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.

Barozzi N, Tett SE. Barozzi N, et al. Clin Ther. 2009 Apr;31(4):849-61. doi: 10.1016/j.clinthera.2009.04.012. Clin Ther. 2009. PMID: 19446158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters